Correction to: ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma (Journal of Neuro-Oncology, (2018), 138, 3, (479-486), 10.1007/s11060-018-2819-3);ATP binding cassette (ABC) transporters: expression and clinical value in glioblastoma

Journal of Neuro-Oncology

Volumn 138, Issue 3, 2018, Pages 479-486

  Dréan, Antonin ^a,b   Rosenberg, Shai ^a,c   Lejeune, François Xavier ^a   Goli, Larissa ^a   Nadaradjane, Aravindan Arun ^a   Guehennec, Jérémy ^a   Schmitt, Charlotte ^a   Verreault, Maïté ^a   Bielle, Franck ^a,d   Mokhtari, Karima ^a,d   Sanson, Marc ^a,d   Carpentier, Alexandre ^d   Delattre, Jean Yves ^a,d   Idbaih, Ahmed ^a,d  

^a SORBONNE UNIVERSITÉ   (France)

^b INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

ABC transporters; ABCA13; Glioblastoma; PDCL; Resistance

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A13; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; MULTIDRUG RESISTANCE PROTEIN 1; TEMOZOLOMIDE; ALKYLATING AGENT; DNA LIGASE; DNA METHYLTRANSFERASE; MESSENGER RNA; MGMT PROTEIN, HUMAN; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER SURVIVAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; GLIOBLASTOMA; GLIOBLASTOMA CELL LINE; HEALTH CARE QUALITY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PROGNOSIS; PROGNOSTIC ASSESSMENT; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR BIOPSY; TUMOR MICROENVIRONMENT; U-251MG CELL LINE; BRAIN TUMOR; CHEMORADIOTHERAPY; DNA METHYLATION; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; PHYSIOLOGY; PROMOTER REGION; SURVIVAL ANALYSIS; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, ALKYLATING; ATP-BINDING CASSETTE TRANSPORTERS; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL LINE, TUMOR; CHEMORADIOTHERAPY; COHORT STUDIES; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; PROGNOSIS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; SURVIVAL ANALYSIS; TEMOZOLOMIDE; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEINS;

EID: 85043400105     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-018-2830-8     Document Type: Erratum

References (27)

1. Ostrom QT, Bauchet L, Davis FG et al (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro-Oncol 16:896–913. 10.1093/neuonc/nou087
2. Dréan A, Goldwirt L, Verreault M et al (2016) Blood-brain barrier, cytotoxic chemotherapies and glioblastoma. Expert Rev Neurother. 10.1080/14737175.2016.1202761
3. Vasiliou V, Vasiliou K, Nebert DW (2009) Human ATP-binding cassette (ABC) transporter family. Hum Genom 3:281–290
4. Hartz AMS, Bauer B (2011) ABC transporters in the CNS - an inventory. Curr Pharm Biotechnol 12:656–673
5. Sparreboom A, Danesi R, Ando Y et al (2003) Pharmacogenomics of ABC transporters and its role in cancer chemotherapy. Drug Resist Updat 6:71–84
6. Khamisipour G, Jadidi-Niaragh F, Jahromi AS et al (2016) Mechanisms of tumor cell resistance to the current targeted-therapy agents. Tumour Biol J Int Soc Oncodev Biol Med 37:10021–10039. 10.1007/s13277-016-5059-1
7. Brennan CW, Verhaak RGW, McKenna A et al (2013) The somatic genomic landscape of glioblastoma. Cell 155:462–477. 10.1016/j.cell.2013.09.034
8. Lundberg E, Fagerberg L, Klevebring D et al (2010) Defining the transcriptome and proteome in three functionally different human cell lines. Mol Syst Biol 6:450. 10.1038/msb.2010.106
9. Uhlén M, Hallström BM, Lindskog C et al (2016) Transcriptomics resources of human tissues and organs. Mol Syst Biol 12:862
10. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996. 10.1056/NEJMoa043330
11. Rosenberg S, Verreault M, Schmitt C et al (2016) Multi-omics analysis of primary glioblastoma cell lines shows recapitulation of pivotal molecular features of parental tumors. Neuro-Oncol. 10.1093/neuonc/now160
12. Kamoun A, Idbaih A, Dehais C et al (2016) Integrated multi-omics analysis of oligodendroglial tumours identifies three subgroups of 1p/19q co-deleted gliomas. Nat Commun 7:11263. 10.1038/ncomms11263
13. Zhang Y, Chen K, Sloan SA et al (2014) An RNA-sequencing transcriptome and splicing database of glia, neurons, and vascular cells of the cerebral cortex. J Neurosci Off J Soc Neurosci 34:11929–11947. 10.1523/JNEUROSCI.1860-14.2014
14. Goldwirt L, Beccaria K, Carpentier A et al (2014) Irinotecan and temozolomide brain distribution: a focus on ABCB1. Cancer Chemother Pharmacol 74:185–193. 10.1007/s00280-014-2490-0
15. Tomioka M, Toda Y, Kurisu J et al (2012) The effects of neurological disorder-related codon variations of ABCA13 on the function of the ABC protein. Biosci Biotechnol Biochem 76:2289–2293. 10.1271/bbb.120563
16. Knight HM, Pickard BS, Maclean A et al (2009) A cytogenetic abnormality and rare coding variants identify ABCA13 as a candidate gene in schizophrenia, bipolar disorder, and depression. Am J Hum Genet 85:833–846. 10.1016/j.ajhg.2009.11.003
17. Dwyer S, Williams H, Jones I et al (2011) Investigation of rare non-synonymous variants at ABCA13 in schizophrenia and bipolar disorder. Mol Psychiatry 16:790–791. 10.1038/mp.2011.2
18. Pickard BS, Van Den Bossche MJA, Malloy MP et al (2012) Multiplex amplicon quantification screening the ABCA13 gene for copy number variation in schizophrenia and bipolar disorder. Psychiatr Genet 22:269–270. 10.1097/YPG.0b013e32835185b3
19. Degenhardt F, Priebe L, Strohmaier J et al (2013) No evidence for an involvement of copy number variation in ABCA13 in schizophrenia, bipolar disorder, or major depressive disorder. Psychiatr Genet 23:45–46. 10.1097/YPG.0b013e328358645b
20. Ma J, Lan X, Gao N et al (2013) A genetic association study between common variants in the ABCA13 gene and schizophrenia in a Han Chinese population. Psychiatry Res 209:748–749. 10.1016/j.psychres.2013.07.013
21. Chen J, Khan RAW, Wang M et al (2016) Association between the variability of the ABCA13 gene and the risk of major depressive disorder and schizophrenia in the Han Chinese population. World J Biol Psychiatry Off J World Fed Soc Biol Psychiatry. 10.1080/15622975.2016.1245442
22. Shah AA, Haynes C, Craig DM et al (2015) Genetic variants associated with vein graft stenosis after coronary artery bypass grafting. Heart Surg Forum 18:E1–E5
23. Yun E-J, Zhou J, Lin C-J et al (2017) The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes. Oncotarget. 10.18632/oncotarget.17756
24. Araújo TM, Seabra AD, Lima EM et al (2016) Recurrent amplification of RTEL1 and ABCA13 and its synergistic effect associated with clinicopathological data of gastric adenocarcinoma. Mol Cytogenet 9:52. 10.1186/s13039-016-0260-x
25. Nymoen DA, Holth A, Hetland Falkenthal TE et al (2015) CIAPIN1 and ABCA13 are markers of poor survival in metastatic ovarian serous carcinoma. Mol Cancer 14:44. 10.1186/s12943-015-0317-1
26. Hlaváč V, Brynychová V, Václavíková R et al (2013) The expression profile of ATP-binding cassette transporter genes in breast carcinoma. Pharmacogenomics 14:515–529. 10.2217/pgs.13.26
27. Hlavata I, Mohelnikova-Duchonova B, Vaclavikova R et al (2012) The role of ABC transporters in progression and clinical outcome of colorectal cancer. Mutagenesis 27:187–196. 10.1093/mutage/ger075